| P2093 | author name string | Nathan Lawrentschuk | |
| | Mahesha Weerakoon | |
| | Liam Toner | |
| | Damien Michael Bolton | |
| | Nikolas Christopher Katelaris | |
| | Phillip Mark Katelaris | |
| P2860 | cites work | ESUR prostate MR guidelines 2012 | Q24620926 |
| | Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation | Q84577525 |
| | Screening for prostate cancer: current status of ERSPC and screening-related issues | Q87300894 |
| | Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis | Q87479767 |
| | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer | Q26849794 |
| | Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer | Q27027567 |
| | Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. | Q30650693 |
| | Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement | Q34288506 |
| | Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. | Q34346871 |
| | Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology | Q34364108 |
| | Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer | Q34459820 |
| | The role of MRI in prostate cancer active surveillance. | Q34705261 |
| | The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer | Q35043569 |
| | Radical prostatectomy versus observation for localized prostate cancer | Q36194308 |
| | Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer | Q36492465 |
| | Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study | Q37145968 |
| | MRI for men undergoing active surveillance or with rising PSA and negative biopsies | Q37798723 |
| | Active surveillance for prostate cancer: a systematic review of the literature | Q38018748 |
| | MR imaging of the prostate | Q38216958 |
| | Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. | Q38220925 |
| | Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice. | Q38272447 |
| | Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review | Q38289798 |
| | Early experience with active surveillance in low-risk prostate cancer treated | Q38306089 |
| | Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? | Q40211703 |
| | The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue. | Q43056789 |
| | Efficacy of using three-tesla magnetic resonance imaging diagnosis of capsule invasion for decision-making about neurovascular bundle preservation in robotic-assisted radical prostatectomy | Q43085945 |
| | Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens. | Q43095308 |
| | Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study | Q43529342 |
| | Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. | Q44759563 |
| | Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. | Q45990544 |
| | Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. | Q51004664 |
| | Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. | Q51010281 |
| | Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology. | Q51074429 |
| | PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. | Q53131398 |
| | Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. | Q53589252 |
| | Bladder cancer: Stem cells repopulate tumours. | Q53660810 |
| | Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. | Q54651228 |
| | Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies | Q56688802 |
| | Clinical Implications of a Multiparametric Magnetic Resonance Imaging Based Nomogram Applied to Prostate Cancer Active Surveillance | Q57317473 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate | Q9625 |
| | magnetic resonance imaging | Q161238 |
| | disease management | Q883708 |
| | prostate neoplasm | Q56014511 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 337-45 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Korean Journal of Urology | Q26842099 |
| P1476 | title | Current role of multiparametric magnetic resonance imaging in the management of prostate cancer | |
| P478 | volume | 56 | |